BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 15609299)

  • 1. ATP-binding cassette superfamily transporter gene expression in human soft tissue sarcomas.
    Oda Y; Saito T; Tateishi N; Ohishi Y; Tamiya S; Yamamoto H; Yokoyama R; Uchiumi T; Iwamoto Y; Kuwano M; Tsuneyoshi M
    Int J Cancer; 2005 May; 114(6):854-62. PubMed ID: 15609299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma.
    Oda Y; Ohishi Y; Saito T; Hinoshita E; Uchiumi T; Kinukawa N; Iwamoto Y; Kohno K; Kuwano M; Tsuneyoshi M
    J Pathol; 2003 Feb; 199(2):251-8. PubMed ID: 12533839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas.
    Hinoshita E; Uchiumi T; Taguchi K; Kinukawa N; Tsuneyoshi M; Maehara Y; Sugimachi K; Kuwano M
    Clin Cancer Res; 2000 Jun; 6(6):2401-7. PubMed ID: 10873092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reverse transcriptase-polymerase chain reaction amplification of MDR1 gene expression in adult soft tissue sarcomas.
    Oda Y; Schneider-Stock R; Ryś J; Gruchała A; Niezabitowski A; Roessner A
    Diagn Mol Pathol; 1996 Jun; 5(2):98-106. PubMed ID: 8727096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma.
    Haga S; Hinoshita E; Ikezaki K; Fukui M; Scheffer GL; Uchiumi T; Kuwano M
    Jpn J Cancer Res; 2001 Feb; 92(2):211-9. PubMed ID: 11223551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of multidrug-resistance-associated protein gene in human soft-tissue sarcomas.
    Oda Y; Schneider-Stock R; Ryś J; Gruchala A; Niezabitowski A; Roessner A
    J Cancer Res Clin Oncol; 1996; 122(3):161-65. PubMed ID: 8601564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance: molecular mechanisms and clinical relevance.
    Ling V
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer resistance protein expression is associated with early recurrence and decreased survival in resectable pancreatic cancer patients.
    Lee SH; Kim H; Hwang JH; Lee HS; Cho JY; Yoon YS; Han HS
    Pathol Int; 2012 Mar; 62(3):167-75. PubMed ID: 22360504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer drug sensitivity and expression of multidrug resistance markers in early passage human sarcomas.
    Hoffmann J; Schmidt-Peter P; Hänsch W; Naundorf H; Bunge A; Becker M; Fichtner I
    Clin Cancer Res; 1999 Aug; 5(8):2198-204. PubMed ID: 10473106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance.
    Li G; Chen X; Wang Q; Xu Z; Zhang W; Ye L
    J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):173-5. PubMed ID: 17497289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP-binding cassette superfamily transporter gene expression in human primary ovarian carcinoma.
    Ohishi Y; Oda Y; Uchiumi T; Kobayashi H; Hirakawa T; Miyamoto S; Kinukawa N; Nakano H; Kuwano M; Tsuneyoshi M
    Clin Cancer Res; 2002 Dec; 8(12):3767-75. PubMed ID: 12473588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas.
    Lacave R; Coulet F; Ricci S; Touboul E; Flahault A; Rateau JG; Cesari D; Lefranc JP; Bernaudin JF
    Br J Cancer; 1998 Mar; 77(5):694-702. PubMed ID: 9514046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of MDR1/p-glycoprotein and multidrug resistance-associated protein in childhood solid tumours.
    Oda Y; Röse I; Radig K; Wagemann W; Mittler U; Roessner A
    Virchows Arch; 1997 Feb; 430(2):99-105. PubMed ID: 9083512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of chemosensitivity measured by histoculture drug response assay to expression of multidrug resistance genes and proteins in gastric cancer].
    Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Keshari RP; Zhang LY
    Ai Zheng; 2009 Apr; 28(4):337-43. PubMed ID: 19622290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the multidrug resistance proteins MRP2 and MRP3 in human cholangiocellular carcinomas.
    Rau S; Autschbach F; Riedel HD; Konig J; Kulaksiz H; Stiehl A; Riemann JF; Rost D
    Eur J Clin Invest; 2008 Feb; 38(2):134-42. PubMed ID: 18226047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatobiliary transporter expression in human hepatocellular carcinoma.
    Zollner G; Wagner M; Fickert P; Silbert D; Fuchsbichler A; Zatloukal K; Denk H; Trauner M
    Liver Int; 2005 Apr; 25(2):367-79. PubMed ID: 15780063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of multidrug resistance proteins, P-gp, MRP1 and LRP, in soft tissue sarcomas analysed according to their histological type and grade.
    Komdeur R; Plaat BE; van der Graaf WT; Hoekstra HJ; Hollema H; van den Berg E; Zwart N; Scheper RJ; Molenaar WM
    Eur J Cancer; 2003 May; 39(7):909-16. PubMed ID: 12706359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of multidrug resistance-associated proteins in bladder cancer during clinical course and drug resistance to doxorubicin.
    Tada Y; Wada M; Migita T; Nagayama J; Hinoshita E; Mochida Y; Maehara Y; Tsuneyoshi M; Kuwano M; Naito S
    Int J Cancer; 2002 Apr; 98(4):630-5. PubMed ID: 11920626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of MDR1 and GST-pi in osteosarcoma and soft tissue sarcoma and their correlation with chemotherapy resistance].
    Wei L; Song XR; Wang XW; Li M; Z uo WS
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):445-8. PubMed ID: 17152492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma].
    Katsaros D; Fracchioli S; Arts HJ; de Vries EG; Danese S; Richiardi G; Arisio R; Gordini G; Van der Zee AG; Suurmeijer AJ; Massobrio M
    Minerva Ginecol; 1999 Dec; 51(12):463-70. PubMed ID: 10767994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.